Indeed, a study using a tumor-bearing mouse model showed that blocking PD-L1 on tumor surface suppressed intracellular glycolysis by inhibition of mTOR activity, suggesting an association between the PD-L1 and mTOR signaling pathways (31). The gene discussed is CD274; the disease is neoplasm.